Caffeic acid 4-O-glucoside

CAS No. 166735-99-5

Caffeic acid 4-O-glucoside( —— )

Catalog No. M32327 CAS No. 166735-99-5

Caffeic acid 4-O-glucoside showed significant axonal elongation effects on Aβ25-35-induced atrophy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 In Stock
10MG 1169 In Stock
25MG 1739 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Caffeic acid 4-O-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Caffeic acid 4-O-glucoside showed significant axonal elongation effects on Aβ25-35-induced atrophy.
  • Description
    Caffeic acid 4-O-glucoside showed significant axonal elongation effects on Aβ25-35-induced atrophy. Caffeic acid 4-O-glucoside has inhibitory effects on the formation of advanced glycation end products (AGEs), the activity of angiotensin-converting (ACE) and acetylcholinesterase (AChE) enzymes.Caffeic acid 4-O-glucoside has radical-scavenging effect.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    166735-99-5
  • Formula Weight
    342.3
  • Molecular Formula
    C15H18O9
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Biosci Biotechnol Biochem . 2010;74(9):1920-1924.
molnova catalog
related products
  • Methyl 11-hydroxyund...

    Methyl 11-hydroxyundecanoate is an emulsifier.

  • β-Amyloid/A4 Protein...

    β-Amyloid/A4 Protein Precusor (319-335) (APP (319-335)) is a peptide fragment of β-Amyloid/A4 protein precursor (APP). β-Amyloid/A4 Protein Precusor (319-335) can recognize the heparinase-insensitive site that contains the neuritotropic activity of APP.

  • BI-1935

    BI-1935 is an inhibitor of soluble epoxide hydrolase (sEH).